ZA944241B - Vaccine containing a serine protease - Google Patents

Vaccine containing a serine protease

Info

Publication number
ZA944241B
ZA944241B ZA944241A ZA944241A ZA944241B ZA 944241 B ZA944241 B ZA 944241B ZA 944241 A ZA944241 A ZA 944241A ZA 944241 A ZA944241 A ZA 944241A ZA 944241 B ZA944241 B ZA 944241B
Authority
ZA
South Africa
Prior art keywords
pct
serine protease
vaccine containing
sec
date
Prior art date
Application number
ZA944241A
Other languages
English (en)
Inventor
John P Dalton
Stuart J Andrews
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Publication of ZA944241B publication Critical patent/ZA944241B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA944241A 1993-06-15 1994-06-15 Vaccine containing a serine protease ZA944241B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939312324A GB9312324D0 (en) 1993-06-15 1993-06-15 Vaccine

Publications (1)

Publication Number Publication Date
ZA944241B true ZA944241B (en) 1995-05-26

Family

ID=10737190

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944241A ZA944241B (en) 1993-06-15 1994-06-15 Vaccine containing a serine protease

Country Status (14)

Country Link
US (1) US5885814A (es)
EP (1) EP0703789B1 (es)
JP (1) JPH08511262A (es)
AT (1) ATE176402T1 (es)
AU (1) AU694121B2 (es)
DE (1) DE69416405T2 (es)
DK (1) DK0703789T3 (es)
ES (1) ES2130426T3 (es)
GB (1) GB9312324D0 (es)
GR (1) GR3030116T3 (es)
HU (1) HUT71209A (es)
NZ (1) NZ267139A (es)
WO (1) WO1994028925A1 (es)
ZA (1) ZA944241B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
AUPO767497A0 (en) * 1997-07-04 1997-07-24 Australian Wool Research & Promotion Organisation Parasite vaccine
US20030065382A1 (en) * 2001-10-02 2003-04-03 Fischell Robert E. Means and method for the treatment of coronary artery obstructions
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
WO2005106012A2 (en) 2004-04-28 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
EP2485725A2 (en) 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001277A1 (en) * 1986-08-18 1988-02-25 The Australian National University Helminth parasite vaccine
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
NZ230773A (en) * 1988-09-26 1993-04-28 Biotech Australia Pty Ltd Nematode antigenic peptides and vaccines
JPH08502404A (ja) * 1992-10-21 1996-03-19 マリンクロット ベテリナリー,アイエヌシー, チオールプロテアーゼを含有するワクチン

Also Published As

Publication number Publication date
DE69416405D1 (de) 1999-03-18
ATE176402T1 (de) 1999-02-15
GR3030116T3 (en) 1999-07-30
ES2130426T3 (es) 1999-07-01
JPH08511262A (ja) 1996-11-26
HU9403591D0 (en) 1995-03-28
HUT71209A (en) 1995-11-28
DK0703789T3 (da) 1999-09-20
GB9312324D0 (en) 1993-07-28
AU6933394A (en) 1995-01-03
NZ267139A (en) 1998-01-26
US5885814A (en) 1999-03-23
EP0703789B1 (en) 1999-02-03
EP0703789A1 (en) 1996-04-03
AU694121B2 (en) 1998-07-16
DE69416405T2 (de) 1999-09-09
WO1994028925A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ATE176593T1 (de) Transdermale wirkstoffzubereitung
HK1001973A1 (en) Sulfonamides
ATE163418T1 (de) Risperidon pamoate
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69332567T2 (de) Inhibitoren von metazoan-parasit-proteasen
GR3030116T3 (en) Vaccine containing a serine protease
DE69332977D1 (de) Thiolprotease enthaltender impfstoff
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
DK0651764T3 (da) Cytotoksisk T-lymfocytantigen som cysteinproteaseinhibitor
ES2122005T3 (es) Medicamento que contiene (-)-metrifonato.
TW353015B (en) Glyphosate liquid formulations
HU9500708D0 (en) Optically active alkylammonium(amino-3phenyl)-1ethanesulfonate derivatives, preparation and use thereof
HU9500709D0 (en) Optically active hydroquinine (amino-3-phenyl)-1-ethanesulfonate, preparation and use thereof
FR2700116B1 (fr) Application d'anticonvulsivants comme radioprotecteurs.